Henry Rodriguez, Ph.D., M.B.A.

Dr. Henry Rodriguez serves as Director of the Office of Cancer Clinical Proteomics Research at the National Cancer Institute (NCI), and is a Senior Scientific Officer at the National Institutes of Health in Bethesda, Maryland.
Rodriguez oversees global oncology programs in proteomics at the NCI, and serves on various committees to develop agreements across Federal agencies, and build public-private partnerships. In addition, Rodriguez is responsible for providing authoritative leadership on innovative technology initiatives that address NCI's expanding role in biomedical research (proteogenomics).
He has authored more than 200 publications, that include 118 original research publications (several in Nature Publishing Group), reviews and chapters, including co-editing a best-selling book entitled "Oxidative Stress and Aging: Advances in Basic Science, Diagnostics and Intervention." Rodriguez serves on the Editorial Boards of Clinical Proteomics, Annals of Laboratory Medicine, Scientific Data (Nature Publishing Group), and the Editorial Advisory Board of Journal of Proteome Research.
Rodriguez has received numerous domestic and international awards and honors, including the Dr. Herbert Wertheim Global Medical Leadership Award, FIU Herbert Wertheim College of Medicine, Leveraging Collaboration Award from the FDA; Director's Award from the NIH and NCI; Diversity Program Alumni Recognition from the Minority Biomedical Research Support program of NIGMS; Young Scientific Investigator Award from Sigma Xi; Distinguished Alumni Member of the Epsilon of Florida Chapter of Phi Beta Kappa at Florida International University, and the Torch Alumni Award from Florida International University.
Rodriguez began his college career at a community college, Miami Dade College, and went on to earn a B.S. in biology (with minor in chemistry) and a M.S. in biology (toxicology), both from Florida International University. He next attained a Ph.D. in cell and molecular biology at Boston University, and did fellowships at The Scripps Research Institute (La Jolla, CA) and at the City of Hope Cancer Center (Duarte, CA). After consulting with mentors, he enrolled at Johns Hopkins Carey Business School, earning there an M.B.A.